Now Available!
Innovation is crucial to cardiovascular care transformation. MedAxiom connects cardiovascular leaders with industry innovators to accelerate critical products and services that improve clinical and operational outcomes.
Discover the latest cardiovascular solutions, news and resources from MedAxiom Industry Partners to take your program to the next level.
MedAxiom works with industry partners to deliver innovative and unique solutions to the cardiovascular care community. These partnerships help member organizations deliver improved value by driving cost out of their systems and increasing efficiencies while improving the quality of care.
The latest MedAxiom Industry Partner announcements and news from industry innovators.
Published: Friday, April 18, 2025
Pritikin finalized its Platform Agreement with Cardiovascular Associates of America (CVAUSA), making it the preferred partner in offering facility-based Intensive Cardiac Rehab to the growing network of 27 CVAUSA medical groups.
Published: Wednesday, April 16, 2025
iCardio.ai is a Los Angeles-based company advancing machine learning and deep learning algorithms for ultrasound, focusing on transthoracic echocardiography. With a proprietary database of over 200 million ultrasound images, iCardio.ai enhances diagnostic accuracy and efficiency through artificial intelligence (AI). Their flagship product, EchoMeasure™, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance, providing clinicians with an automated, comprehensive imaging workflow and preliminary reporting tool. Additionally, CardioVision™, an AI-based aortic stenosis detection tool, earned FDA Breakthrough Device Designation, addressing unmet needs in cardiac diagnostics. iCardio.ai has also formed key partnerships, including a multi-year collaboration with GE Healthcare to integrate its technology into GE ultrasound platforms, as well as agreements with UltraLinQ and SARC MedIQ, broadening the accessibility and utility of echocardiography AI.
Published: Tuesday, April 8, 2025
Caristo Diagnostics, developer of a new artificial intelligence (AI)-powered heart disease detection solution allowing healthcare providers to identify hidden heart attack risks before symptoms appear.
Published: Monday, March 31, 2025
US Heart & Vascular (USHV), a leading national provider of support services to cardiovascular physician practices, enabling independent cardiologists to increase patient access, improve outcomes, and reduce costs to the healthcare system.
Published: Thursday, March 6, 2025
Bunkerhill Health, a leader in AI-enabled early disease detection, and Cleerly, a pioneer in advanced cardiovascular imaging, have announced a strategic partnership to expand access to their technologies for coronary artery disease (CAD) detection and risk assessment.
Published: Thursday, January 23, 2025
Cardiologists face growing challenges each year, including declining reimbursements, rising operational costs, difficulties in recruiting staff, and intensified competition from large healthcare organizations.Published: Thursday, December 19, 2024
Barnes-Jewish Hospital (BJH) has partnered with Biome Analytics to achieve groundbreaking improvements in reducing Acute Kidney Injury (AKI) rates among cardiovascular patients.
Published: Tuesday, December 17, 2024
Cleerly, a leader in advanced cardiovascular imaging, announced the successful closure of its Series C extension funding round, raising a total of $106 million.
Numerous Industry educational webinars are presented throughout the year to support knowledge sharing within the cardiovascular healthcare community.
Numerous Industry videos are produced throughout the year to support innovation sharing within the cardiovascular healthcare community.
From CV business white papers and data-driven reports to roadmaps for implementing new technologies, these publications arm you with the knowledge needed to transform cardiovascular care.
These publications were developed by MedAxiom with support from Industry Partners and are intended for informational purposes only. The statements and/or opinions expressed do not represent official American College of Cardiology (ACC) opinions, positions, policies or clinical guidance unless otherwise stated. These publications do not constitute a guarantee or endorsement of a specific product or therapy by MedAxiom or the ACC.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
_lrg.png)
_lrg.png)
_Pacemate_Co-Sponsor_lrg.PNG)
_lrg.PNG)
